Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HABENOX: Enoxaparin +/- Aspirin for Habitual Abortion
NCT00959621Phase 3Completed
- Sponsor
- University of Helsinki
- Start
- Jan 2002
- Primary completion
- Dec 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of enoxaparin in recurrent pregnancy loss (RPL) (3 arms), sponsored by University of Helsinki. Primary endpoints: Live births and Premature live births. Started Jan 2002; status: completed.
02
Drugs
enoxaparin
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT00959621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959621.